Cargando…

Association of preceding antithrombotic therapy in atrial fibrillation patients with ischaemic stroke, intracranial haemorrhage, or gastrointestinal bleed and mortality

AIMS: To analyse 90-day mortality in atrial fibrillation (AF) patients after a stroke or a severe bleed and assess associations with the type of antithrombotic treatment at the event. METHODS AND RESULTS: From the Stockholm Healthcare database, we selected 6017 patients with a known history of AF wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Komen, Joris J, Forslund, Tomas, Mantel-Teeuwisse, Aukje K, Klungel, Olaf H, von Euler, Mia, Braunschweig, Frieder, Wallén, Håkan, Hjemdahl, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811399/ https://www.ncbi.nlm.nih.gov/pubmed/31665368 http://dx.doi.org/10.1093/ehjcvp/pvz063

Ejemplares similares

Response to: Kumar N, Ahmed M. Letter to the editor in response to Komen et al. 2021
por: Komen, Joris J, et al.
Publicado: (2021)

Long-term persistence and adherence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk
por: Komen, Joris J, et al.
Publicado: (2020)

Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds
por: Komen, Joris, et al.
Publicado: (2022)

Factors associated with antithrombotic treatment decisions for stroke prevention in atrial fibrillation in the Stockholm region after the introduction of NOACs
por: Komen, Joris, et al.
Publicado: (2017)

Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study( )
por: Komen, Joris J, et al.
Publicado: (2022)

Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries
por: Komen, Joris J, et al.
Publicado: (2021)

Access to oxytocin and misoprostol for management of postpartum haemorrhage in Kenya, Uganda and Zambia: a cross-sectional assessment of availability, prices and affordability
por: Kibira, Denis, et al.
Publicado: (2021)

Impact of regulatory requirements on medicine registration in African countries – perceptions and experiences of pharmaceutical companies in South Africa
por: Narsai, Kirti, et al.
Publicado: (2012)

Greedy caliper propensity score matching can yield variable estimates of the treatment‐outcome association—A simulation study
por: Komen, Joris J., et al.
Publicado: (2021)

Pre‐approval and post‐approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs
por: Bloem, Lourens T., et al.
Publicado: (2022)

Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study
por: Sagwa, Evans L, et al.
Publicado: (2014)

Regulatory Scientific Advice on Non-Inferiority Drug Trials
por: Wangge, Grace, et al.
Publicado: (2013)

The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs
por: Vreman, Rick A., et al.
Publicado: (2020)

Mechanical thrombectomy in acute ischaemic stroke patients with pre-interventional intracranial haemorrhage following intravenous thrombolysis
por: Styczen, Hanna, et al.
Publicado: (2021)

Antiplatelets/antithrombotics: Spontaneous intracerebral haemorrhage: case report
Publicado: (2021)

Risk of intracranial haemorrhage and ischaemic stroke after convexity subarachnoid haemorrhage in cerebral amyloid angiopathy: international individual patient data pooled analysis
por: Hostettler, Isabel Charlotte, et al.
Publicado: (2021)

Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies
por: Bloem, Lourens T., et al.
Publicado: (2021)

Availability, prices and affordability of UN Commission’s lifesaving medicines for reproductive and maternal health in Uganda
por: Kibira, Denis, et al.
Publicado: (2017)

Valproic acid utilization among girls and women in Stockholm: Impact of regulatory restrictions
por: Karlsson Lind, Linnéa, et al.
Publicado: (2018)

Low LDL-C level and intracranial haemorrhage risk after ischaemic stroke: a prospective cohort study
por: Xu, Jie, et al.
Publicado: (2022)

Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines Lists
por: Bazargani, Yaser T., et al.
Publicado: (2014)

Characteristics of drugs safety signals that predict safety related product information update
por: Insani, Widya N., et al.
Publicado: (2018)

The double opioid crisis: A call for balance
por: Vranken, Marjolein J.M., et al.
Publicado: (2019)

Systematic reviews of ten pharmaceutical pricing policies – a research protocol
por: Tordrup, David, et al.
Publicado: (2020)

Pre‐ and post‐stroke oral antithrombotics and mortality in patients with ischaemic stroke
por: García Rodríguez, Luis A., et al.
Publicado: (2022)

Price changes of antibiotics and perceived substitutes in the context of OTC policy changes in Mexico and Brazil
por: Santa-Ana-Tellez, Yared, et al.
Publicado: (2015)

Five-year trends in treatment changes in an adult cohort of HIV/AIDS patients in Ghana: a retrospective cohort study
por: Ankrah, Daniel N. A., et al.
Publicado: (2017)

Sustainable Development Goal indicator for measuring availability and affordability of medicines for children: a proof-of-concept study
por: Joosse, Iris R, et al.
Publicado: (2023)

When Reality Does Not Meet Expectations—Experiences and Perceived Attitudes of Dutch Stakeholders Regarding Payment and Reimbursement Models for High-Priced Hospital Drugs
por: Callenbach, Marcelien H. E., et al.
Publicado: (2022)

The changing multiple sclerosis treatment landscape: impact of new drugs and treatment recommendations
por: Eriksson, Irene, et al.
Publicado: (2018)

Antithrombotic treatment switching in elderly patients with atrial fibrillation and the risk of thromboembolism, bleeding, and cardiac death
por: Ehrlinder, Hanne, et al.
Publicado: (2022)

Essential Medicines Are More Available than Other Medicines around the Globe
por: Bazargani, Yaser T., et al.
Publicado: (2014)

Real World Data in Health Technology Assessment of Complex Health Technologies
por: Hogervorst, Milou A., et al.
Publicado: (2022)

Newer long-acting insulin prescriptions for patients with type 2 diabetes: prevalence and practice variation in a retrospective cohort study
por: Dankers, Marloes, et al.
Publicado: (2022)

Longitudinal study of Good Pharmacy Practice roles covered at the annual world pharmacy congresses 2003–2019
por: Kusynová, Zuzana, et al.
Publicado: (2022)

Marketing of medicines in primary care: An analysis of direct marketing mailings and advertisements
por: Dankers, Marloes, et al.
Publicado: (2023)

Desmopressin Acetate in Intracranial Haemorrhage
por: Kapapa, Thomas, et al.
Publicado: (2014)

Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study
por: Wilson, Duncan, et al.
Publicado: (2018)

Clinical Presentation, Treatment, and Outcome of Nontraumatic Subarachnoid Hemorrhage in Patients with Preceding Antithrombotic Therapy
por: UNO, Masaaki, et al.
Publicado: (2022)

Early Risk of Stroke in Patients Undergoing Acute Versus Elective Cardioversion for Atrial Fibrillation
por: Forslund, Tomas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ab5egd4h9o41k3a1o7ick88v0t